Planned Parenthood of the Pacific Southwest
Planned Parenthood of the Pacific Southwest was paid $17.68M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 14% of everything it billed.
SAN DIEGO, CA 92101
Next to other Non-Pharmacy Dispensing Site providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,853 | $2.60M | |
| 2019 | 49,240 | $2.18M | |
| 2020 | 51,323 | $2.11M | |
| 2021 | 61,787 | $2.73M | |
| 2022 | 83,729 | $3.43M | |
| 2023 | 72,519 | $2.82M | |
| 2024incomplete | 37,193 | $1.80M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14% | 53,634 | 52,450 | $2.43M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13% | 53,652 | 52,471 | $2.31M |
| 59840 | 12% | 6,036 | 5,698 | $2.20M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 21,000 | 20,644 | $1.70M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 31,775 | 31,237 | $1.63M |
| J3490 | Unclassified drugs | 6.7% | 20,002 | 19,156 | $1.18M |
| S4993 | Contraceptive pills for birth control | 5.4% | 8,325 | 8,266 | $958K |
| 87806 | 4.5% | 33,827 | 33,533 | $802K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.8% | 17,276 | 16,970 | $667K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.4% | 20,357 | 20,052 | $605K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3.0% | 654 | 636 | $529K |
| 58300 | 1.9% | 2,624 | 1,815 | $342K |
38 more codes
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 1.8% | 581 | $310K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.7% | 7,500 | $292K |
| 99152 | 1.6% | 5,599 | $283K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 1,658 | $197K |
| A4267 | Contraceptive supply, condom, male, each | <1% | 14,409 | $176K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,362 | $118K |
| 81025 | <1% | 37,441 | $99K | |
| 11981 | <1% | 650 | $93K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 110 | $76K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,160 | $74K |
| 59841 | <1% | 118 | $65K | |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 107 | $60K |
| 55250 | <1% | 378 | $56K | |
| 87529 | <1% | 944 | $55K | |
| 99201 | <1% | 1,071 | $47K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 726 | $41K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 430 | $38K |
| 87210 | <1% | 10,778 | $38K | |
| 99000 | <1% | 10,776 | $35K | |
| 83986 | <1% | 10,706 | $33K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,749 | $30K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 32 | $23K |
| S5199 | Personal care item, nos, each | <1% | 2,221 | $17K |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 13 | $16K |
| 85018 | <1% | 8,846 | $8K | |
| 99401 | <1% | 330 | $6K | |
| 86701 | <1% | 814 | $6K | |
| 57460 | <1% | 47 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 94 | $5K |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 13 | $5K |
| 81002 | <1% | 2,195 | $5K | |
| 11976 | <1% | 43 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 140 | $3K |
| 86901 | <1% | 1,166 | $2K | |
| 76998 | <1% | 43 | $2K | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 788 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 432 | $158.55 |
| S5000 | Prescription drug, generic | <1% | 12 | $27.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.